Estrella Immunopharma, Inc.

Q2 2026 13F Holders

Symbol
ESLA
CUSIP
297584104
Type
Equity
Class
COM
Num filings
15
Total reported value, excl. options
$4.99 M
Manager Report Date Value ($000) Shares Option Type